RE: Great update !27 Apr 2021 11:42
I agree with you iceman888 - I have just sat down and read the whole rns and if my understanding is right they are looking to out licence hopefully at least 2 products this yr.
They are in collaborations still with the japanese pharma for 301
They are working with biocat - re potential treatment for covid and pn going works
They are using pyc to assist with val201 and if I've understood correctly 401
They believe the combination of their drug with a known cancer drug would be given approval
Cash balance is good
No raise foreseen for at least 12 months
Cost cutting and a clear path for the company over the forth coming 2-3 yrs.
I dont think Suzy could have set it out any clear re the vision of the company, what is has happened upto 31.12.20,. Got to say I'm really impressed and imo only anyone reading the rns and looking at it negatively, I cant see any negative myself.
The reference re hemo,I'm in that share and did not foresee the complete lack of cover for shareholders with the CLNs with mint.
VAL from what i can see is protecting and enhancing shareholder value at every step that it can. Things take time, I guess that's why they call it investing.
Granted though I completely get that anyone holding from old have been waiting a long time and anyone caught on the spike is deep underwater but I truly think they are doing what's best for shareholders now. Imo
Good luck all and happy tuesday